{"filing":{"accession_number":"0001193125-26-331594","cik":"0001856725","ticker":"RANI","company_name":"Rani Therapeutics Holdings, Inc.","form":"8-K","filing_date":"2026-08-04","report_date":"2026-08-01","primary_document":"d177572d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1856725/000119312526331594/d177572d8k.htm"},"events":[{"id":23873,"run_id":21590,"accession_number":"0001193125-26-331594","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Michelle Gilson was appointed to the Board of Directors effective August 1, 2026, and simultaneously appointed as chair of the Audit Committee. This is a clear executive appointment of a director and committee chair with relevant biotechnology and financial expertise. Board appointments and committee leadership changes are material governance events affecting the registrant's leadership structure.","company_name":"Rani Therapeutics Holdings, Inc.","ticker":"RANI","filing_date":"2026-08-04","form":"8-K","submitted_at":null,"items":[{"id":24224,"accession_number":"0001193125-26-331594","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Michelle Gilson was appointed to the Board of Directors effective August 1, 2026, and simultaneously appointed as chair of the Audit Committee. This is a clear executive appointment of a director and committee chair with relevant biotechnology and financial expertise. Board appointments and committee leadership changes are material governance events affecting the registrant's leadership structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-05T02:24:02.736934+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":24224,"accession_number":"0001193125-26-331594","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Michelle Gilson was appointed to the Board of Directors effective August 1, 2026, and simultaneously appointed as chair of the Audit Committee. This is a clear executive appointment of a director and committee chair with relevant biotechnology and financial expertise. Board appointments and committee leadership changes are material governance events affecting the registrant's leadership structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-05T02:24:02.736934+00:00","company_name":"Rani Therapeutics Holdings, Inc.","ticker":"RANI","filing_date":"2026-08-04"}]}